Developer docs
API playgroundTry for free, no card

Search company profiles

Unichem Pharmaceuticals

Full company profile

uuid00084we

Namestring
Unichem Pharmaceuticals
Websiteurl
unichemusa.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Unichem Pharmaceuticals is a private, for-profit manufacturer and distributor of label generic pharmaceutical products, headquartered in East Brunswick, New Jersey. Founded in 2005, the company operates with a workforce sized at 11 to 50 employees, placing it firmly in the small-enterprise segment of the US generics market. Publicly disclosed leadership is limited to a single named executive, Scott B. Delaney, who holds the combined role of President and CEO. The firm's operating footprint, customer base, and product mix beyond the broad 'label generic pharmaceutical products' descriptor are not disclosed in the source material.

The company's product portfolio, manufacturing capabilities, packaging lines, and channel strategy are not specified in any available source. There is no disclosure of dosage forms, therapeutic categories, API sourcing arrangements, manufacturing certifications (FDA, cGMP, DEA), or facility locations beyond the East Brunswick headquarters. The company's website at unichemusa.com returned only a verification/loading page during data capture and yielded no substantive content. Likewise, there is no public technology stack, no proprietary platform, and no patent or trademark record disclosed, leaving the technical underpinning of the operation uncharacterized from external signals alone.

The revenue model, pricing structure, contract terms, and customer segmentation are entirely unspecified in the source material. No funding history, M&A activity, partnership, customer logo, geographic expansion, regulatory action, or leadership change beyond the single CEO entry is documented. Ownership, capitalization, and governance are similarly opaque. This produces a material data gap: while the firmographic spine (name, location, sector, founding year, headcount band, CEO) is intact, virtually all commercially and strategically relevant dimensions are blank, and any analytical conclusion beyond confirming the company's basic identity should be treated as preliminary pending first-party disclosure.

Short descriptiontext

Unichem Pharmaceuticals is a private US-based manufacturer and distributor of label generic pharmaceutical products, headquartered in East Brunswick, New Jersey. Founded in 2005, it operates with 11 to 50 employees under President and CEO Scott B. Delaney.

Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersEast Brunswick, United States
HQ citystring
East Brunswick
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
generic pharmaceuticals, pharmaceutical manufacturing, drug distribution, label medications, pharmaceutical products
Industry1 code
PRIMARYHLAIABAH
Generic Finished Dosage Form (FDF) Manufacturing
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic Pharmaceuticals
No data
Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Unichem Pharmaceuticals is a manufacturing company that produces and distributes label generic pharmaceutical products. The company formulates and ships generic medications intended for downstream commercial buyers in the pharmaceutical supply chain. Specific product lines, SKUs, or therapeutic categories are not documented in available source material.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Label generic pharmaceutical products
CategoryGeneric Pharmaceuticals
Description

Manufactured label generic pharmaceutical products distributed to downstream buyers in the U.S. pharmaceutical supply chain. Specific SKUs, therapeutic categories, or product-level details are not documented in available source material.

No data
Peers10 records
1Sun Pharmaceutical Industries
TypeBroad incumbent
Description

India-based generic manufacturer with a sizeable US presence in finished dosage generics and specialty formulations; overlaps with Unichem in core generic manufacturing and US distribution.

TypeBroad incumbent
Description

US operations of a major India-based generic manufacturer offering an extensive portfolio of generic formulations across therapeutic categories — broader scale, but directly overlapping in product and channel.

TypeBroad incumbent
Description

Large Canadian-headquartered generic manufacturer with substantial US operations producing finished dosage generics for retail and institutional channels.

TypeDirect peer
Description

US arm of an India-headquartered manufacturer with a broad portfolio of generic finished dosage forms distributed throughout the US market.

TypeBroad incumbent
Description

The largest US generic manufacturer, offering the broadest small-molecule generic portfolio and unmatched distribution scale; competes with Unichem across nearly every retail generic category.

TypeDirect peer
Description

US-focused, small-to-mid cap generic drug manufacturer with a similar product portfolio of finished dosage generics and a comparable sales channel focus on wholesalers, distributors, and pharmacy customers.

7Heritage Pharmaceuticals (Amneal)
TypeDirect peer
Description

Generic pharmaceuticals manufacturer distributing broad-line small-molecule generics to US retailers and institutions — directly comparable in product type, channel, and customer base to Unichem.

TypeDirect peer
Description

US subsidiary of an India-based generic manufacturer producing oral solids and other generic dosage forms distributed through US wholesalers and pharmacy chains.

TypeBroad incumbent
Description

US-headquartered specialty and generics manufacturer with a broad small-molecule generics portfolio and integrated distribution; comparable across product, channel, and US customer base.

TypeBroad incumbent
Description

Global leader in off-patent medicines including generic finished dosage forms, with deep US retail and hospital channel coverage; sets benchmark pricing Unichem must compete against.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Unichem Pharmaceuticals

Generic Pharmaceuticalsunichemusa.com

Unichem Pharmaceuticals is a private US-based manufacturer and distributor of label generic pharmaceutical products, headquartered in East Brunswick, New Jersey. Founded in 2005, it operates with 11 to 50 employees under President and CEO Scott B. Delaney.

What Unichem Pharmaceuticals does

Unichem Pharmaceuticals is a private, for-profit manufacturer and distributor of label generic pharmaceutical products, headquartered in East Brunswick, New Jersey. Founded in 2005, the company operates with a workforce sized at 11 to 50 employees, placing it firmly in the small-enterprise segment of the US generics market. Publicly disclosed leadership is limited to a single named executive, Scott B. Delaney, who holds the combined role of President and CEO. The firm's operating footprint, customer base, and product mix beyond the broad 'label generic pharmaceutical products' descriptor are not disclosed in the source material.

The company's product portfolio, manufacturing capabilities, packaging lines, and channel strategy are not specified in any available source. There is no disclosure of dosage forms, therapeutic categories, API sourcing arrangements, manufacturing certifications (FDA, cGMP, DEA), or facility locations beyond the East Brunswick headquarters. The company's website at unichemusa.com returned only a verification/loading page during data capture and yielded no substantive content. Likewise, there is no public technology stack, no proprietary platform, and no patent or trademark record disclosed, leaving the technical underpinning of the operation uncharacterized from external signals alone.

The revenue model, pricing structure, contract terms, and customer segmentation are entirely unspecified in the source material. No funding history, M&A activity, partnership, customer logo, geographic expansion, regulatory action, or leadership change beyond the single CEO entry is documented. Ownership, capitalization, and governance are similarly opaque. This produces a material data gap: while the firmographic spine (name, location, sector, founding year, headcount band, CEO) is intact, virtually all commercially and strategically relevant dimensions are blank, and any analytical conclusion beyond confirming the company's basic identity should be treated as preliminary pending first-party disclosure.

Unichem Pharmaceuticals firmographics

Firmographics
Name
Unichem Pharmaceuticals
Website
https://unichemusa.com
Company type
Private
Founded year
2005
Headcount range
51–100 employees
Short description
Unichem Pharmaceuticals is a private US-based manufacturer and distributor of label generic pharmaceutical products, headquartered in East Brunswick, New Jersey. Founded in 2005, it operates with 11 to 50 employees under President and CEO Scott B. Delaney.
Ownership category
akta.pro rank

Unichem Pharmaceuticals industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIABAH
Generic Finished Dosage Form (FDF) Manufacturing

Keywords

  • Generic pharmaceuticals
  • Pharmaceutical manufacturing
  • Drug distribution
  • Label medications
  • Pharmaceutical products

Where Unichem Pharmaceuticals is headquartered

Location

Headquarters

HQ city
East Brunswick
HQ country
United States
HQ region
North America

Markets served

Unichem Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Unichem Pharmaceuticals product offering

Product offering

Core offering

Unichem Pharmaceuticals is a manufacturing company that produces and distributes label generic pharmaceutical products. The company formulates and ships generic medications intended for downstream commercial buyers in the pharmaceutical supply chain. Specific product lines, SKUs, or therapeutic categories are not documented in available source material.

Differentiator

Problem solved

Functional benefit

Products and services

  • Label generic pharmaceutical products Manufactured label generic pharmaceutical products distributed to downstream buyers in the U.S. pharmaceutical supply chain. Specific SKUs, therapeutic categories, or product-level details are not documented in available source material.

Companies that use Unichem Pharmaceuticals

Customer profile

Ideal customer profiles1 record

Unichem Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Unichem Pharmaceuticals competitors and assessment

Company assessment

Broad incumbents

  • Sun Pharmaceutical Industries: India-based generic manufacturer with a sizeable US presence in finished dosage generics and specialty formulations; overlaps with Unichem in core generic manufacturing and US distribution.
  • Aurobindo Pharma USA: US operations of a major India-based generic manufacturer offering an extensive portfolio of generic formulations across therapeutic categories — broader scale, but directly overlapping in product and channel.
  • Apotex Corp: Large Canadian-headquartered generic manufacturer with substantial US operations producing finished dosage generics for retail and institutional channels.
  • Teva Pharmaceutical Industries: The largest US generic manufacturer, offering the broadest small-molecule generic portfolio and unmatched distribution scale; competes with Unichem across nearly every retail generic category.
  • Amneal Pharmaceuticals: US-headquartered specialty and generics manufacturer with a broad small-molecule generics portfolio and integrated distribution; comparable across product, channel, and US customer base.
  • Sandoz (Novartis): Global leader in off-patent medicines including generic finished dosage forms, with deep US retail and hospital channel coverage; sets benchmark pricing Unichem must compete against.

Direct peers

  • Zydus Pharmaceuticals (USA): US arm of an India-headquartered manufacturer with a broad portfolio of generic finished dosage forms distributed throughout the US market.
  • Lannett Company: US-focused, small-to-mid cap generic drug manufacturer with a similar product portfolio of finished dosage generics and a comparable sales channel focus on wholesalers, distributors, and pharmacy customers.
  • Heritage Pharmaceuticals (Amneal): Generic pharmaceuticals manufacturer distributing broad-line small-molecule generics to US retailers and institutions — directly comparable in product type, channel, and customer base to Unichem.
  • Glenmark Pharmaceuticals USA: US subsidiary of an India-based generic manufacturer producing oral solids and other generic dosage forms distributed through US wholesalers and pharmacy chains.

Market position

Strengths3 records

Weaknesses3 records

Key risks4 records

Key highlights3 records

Customer concentration

Unichem Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Unichem Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles1 record

Unichem Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Unichem Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Unichem Pharmaceuticals

What does Unichem Pharmaceuticals do?

Unichem Pharmaceuticals is a manufacturing company that produces and distributes label generic pharmaceutical products. The company formulates and ships generic medications intended for downstream commercial buyers in the pharmaceutical supply chain. Specific product lines, SKUs, or therapeutic categories are not documented in available source material.

When was Unichem Pharmaceuticals founded?

Unichem Pharmaceuticals was founded in 2005. It employs 51 to 100 people.

Where is Unichem Pharmaceuticals based?

Unichem Pharmaceuticals is headquartered in East Brunswick, United States, in the North America region.

Who are Unichem Pharmaceuticals's main competitors?

Broad incumbents on record are Sun Pharmaceutical Industries, Aurobindo Pharma USA, Apotex Corp, Teva Pharmaceutical Industries, Amneal Pharmaceuticals and Sandoz (Novartis). Direct peers are Zydus Pharmaceuticals (USA), Lannett Company, Heritage Pharmaceuticals (Amneal) and Glenmark Pharmaceuticals USA.

Does Unichem Pharmaceuticals have an API?

No public API is recorded for Unichem Pharmaceuticals.

What industry is Unichem Pharmaceuticals in?

Unichem Pharmaceuticals's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals